New York, NYNCT06780709Now EnrollingIRB Ready

Neuromyelitis Optica Spectrum Disorder (NMOSD) Clinical Trial in New York, NY

Access cutting-edge neuromyelitis optica spectrum disorder (nmosd) treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Icahn School of Medicine at Mount Sinai

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access neuromyelitis optica spectrum disorder (nmosd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuromyelitis optica spectrum disorder (nmosd) treatment provided free

Apply for This New York Location

Check if you qualify for this neuromyelitis optica spectrum disorder (nmosd) clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Neuromyelitis Optica Spectrum Disorder (NMOSD) Study in New York

This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.

Sponsor: Icahn School of Medicine at Mount Sinai

Who Can Participate

Inclusion Criteria

Adults (age ≥18) with NMOSD diagnosed with 2015 NMOSD clinical criteria.
All EDSS scores will be considered in order to make the intervention accessible to all patients regardless of disability.
All patients regardless of treatment type will be considered.

Exclusion Criteria

Inability to voluntarily provide consent for study participation
Inability to participate in study evaluation and/or endpoint measures, or participation in another concurrent randomized controlled trial or wellness based intervention.
Any patients with a relapse within 30 days of randomization or any patients with medical restrictions on physical activity will be excluded.
Any patients who begin stimulants and/or dalfampridine between enrollment and randomization will be excluded.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06780709) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment Options in New York, NY

If you're searching for neuromyelitis optica spectrum disorder (nmosd) treatment options in New York, NY, this clinical trial (NCT06780709) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuromyelitis optica spectrum disorder (nmosd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuromyelitis optica spectrum disorder (nmosd) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in New York, NY

See all pulmonary embolism clinical trials recruiting in New York — not just this study.

Browse Pulmonary Embolism Trials in New York →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY